← Leaderboards
Yin Wang
University Of Michigan At Ann Arbor
$2,655,608
Attributed
$2,655,608
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $767.6K · FY2012–22$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,655,608 · 3
By mechanism
R01$2,276,853 · 2
R21$378,755 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sami Nimer Malek$8,691,121
- Brian Francis Zamarron$90,176
- Shaomeng Wang$36,139,079
- Tomasz Cierpicki$10,333,927
- Pavan Reddy$35,237,005
Others in their field
Top investigators on “Cell Physiology”
- John M Lachin · George Washington University$136,828,043
- David Heimbrook · Leidos Biomedical Research, Inc.$126,416,403
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Garret A Fitzgerald · University Of Pennsylvania$103,979,378
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Dennis R. Burton · Scripps Research Institute$60,915,824
Research focus
Cell PhysiologySignal PathwayIn VivoAntibodiesCancer TherapyResponseLeadPlayCancer PatientInnovationTumorPreventPublicationsPatternProteinsMutationLeukemiaNeoplastic CellHematologic NeoplasmsCancer CellMalignant NeoplasmsMolecularPathway InteractionsTumor Growth
Grant awards (8)
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children$404,582
R01 · FY2022 · CA · contact PI
Anticancer peptide therapeutics$346,350
R01 · FY2022 · CA · contact PI
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children$414,188
R01 · FY2021 · CA · contact PI
Anticancer peptide therapeutics$353,419
R01 · FY2021 · CA · contact PI
A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children$415,499
R01 · FY2020 · CA · contact PI
Anticancer peptide therapeutics$342,815
R01 · FY2019 · CA · contact PI
Molecular Programs for Stem Cells of Hematological Malignancies$175,827
R21 · FY2013 · CA · contact PI
Molecular Programs for Stem Cells of Hematological Malignancies$202,928
R21 · FY2012 · CA · contact PI